These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 18182620)

  • 1. Regulation of telomerase and telomeres: human tumor viruses take control.
    Bellon M; Nicot C
    J Natl Cancer Inst; 2008 Jan; 100(2):98-108. PubMed ID: 18182620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms.
    Horikawa I; Barrett JC
    Carcinogenesis; 2003 Jul; 24(7):1167-76. PubMed ID: 12807729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced senescence in HeLa cervical carcinoma cells containing elevated telomerase activity and extended telomeres.
    Goodwin EC; DiMaio D
    Cell Growth Differ; 2001 Nov; 12(11):525-34. PubMed ID: 11714633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human tumor-associated viruses and new insights into the molecular mechanisms of cancer.
    Martin D; Gutkind JS
    Oncogene; 2008 Dec; 27 Suppl 2():S31-42. PubMed ID: 19956178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor viruses and replicative immortality--avoiding the telomere hurdle.
    Chen X; Kamranvar SA; Masucci MG
    Semin Cancer Biol; 2014 Jun; 26():43-51. PubMed ID: 24486644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple levels of telomerase regulation.
    Stewart SA
    Mol Interv; 2002 Dec; 2(8):481-3. PubMed ID: 14993399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
    Saini N; Srinivasan R; Chawla Y; Sharma S; Chakraborti A; Rajwanshi A
    Liver Int; 2009 Sep; 29(8):1162-70. PubMed ID: 19627485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue formation and tissue engineering through host cell recruitment or a potential injectable cell-based biocomposite with replicative potential: Molecular mechanisms controlling cellular senescence and the involvement of controlled transient telomerase activation therapies.
    Babizhayev MA; Yegorov YE
    J Biomed Mater Res A; 2015 Dec; 103(12):3993-4023. PubMed ID: 26034007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncanonical functions of telomerase and telomeres in viruses-associated cancer.
    Rasouli S; Dakic A; Wang QE; Mitchell D; Blakaj DM; Putluri N; Li J; Liu X
    J Med Virol; 2024 May; 96(5):e29665. PubMed ID: 38738582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase regulation and progressive telomere shortening of rat hepatic stem-like epithelial cells during in vitro aging.
    Oh BK; Lee CH; Park C; Park YN
    Exp Cell Res; 2004 Aug; 298(2):445-54. PubMed ID: 15265692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomere Dynamics in Immune Senescence and Exhaustion Triggered by Chronic Viral Infection.
    Bellon M; Nicot C
    Viruses; 2017 Oct; 9(10):. PubMed ID: 28981470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase inhibition in RenCa, a murine tumor cell line with short telomeres, by overexpression of a dominant negative mTERT mutant, reveals fundamental differences in telomerase regulation between human and murine cells.
    Sachsinger J; González-Suárez E; Samper E; Heicappell R; Müller M; Blasco MA
    Cancer Res; 2001 Jul; 61(14):5580-6. PubMed ID: 11454711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase Biology Associations Offer Keys to Cancer and Aging Therapeutics.
    Smith-Sonneborn J
    Curr Aging Sci; 2020; 13(1):11-21. PubMed ID: 31544708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells.
    Chen R; Zhu J; Dong Y; He C; Hu X
    Oncotarget; 2015 Oct; 6(32):32841-55. PubMed ID: 26418880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential timing of oxidative DNA damage and telomere shortening in hepatitis C and B virus-related liver carcinogenesis.
    Piciocchi M; Cardin R; Cillo U; Vitale A; Cappon A; Mescoli C; Guido M; Rugge M; Burra P; Floreani A; Farinati F
    Transl Res; 2016 Feb; 168():122-133. PubMed ID: 26408804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomeres, telomerase, and myc. An update.
    Cerni C
    Mutat Res; 2000 Jan; 462(1):31-47. PubMed ID: 10648922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase: a crucial player in HTLV-I-induced human T-cell leukemia.
    Bellon M; Nicot C
    Cancer Genomics Proteomics; 2007; 4(1):21-5. PubMed ID: 17726237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass cultured human fibroblasts overexpressing hTERT encounter a growth crisis following an extended period of proliferation.
    MacKenzie KL; Franco S; May C; Sadelain M; Moore MA
    Exp Cell Res; 2000 Sep; 259(2):336-50. PubMed ID: 10964501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players.
    Yuan X; Larsson C; Xu D
    Oncogene; 2019 Aug; 38(34):6172-6183. PubMed ID: 31285550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase inhibition in a mouse cell line with long telomeres leads to rapid telomerase reactivation.
    Marie-Egyptienne DT; Brault ME; Zhu S; Autexier C
    Exp Cell Res; 2008 Feb; 314(3):668-75. PubMed ID: 18067891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.